Soy protein, isoflavonoids, and risk of developing coronary heart disease Alice H. Lichtenstein OriginalPaper Pages: 210 - 214
Nut consumption and risk of coronary heart disease: A review of epidemiologic evidence Frank B. HuMeir J. Stampfer ReviewPaper Pages: 204 - 209
Genetic predictors of plasma lipid response to diet intervention Jose M. OrdovasJennifer R. Galluzzi OriginalPaper Pages: 196 - 203
Effects of diet and of dietary components on endothelial leukocyte adhesion molecules Raffaele De CaterinaMarika Massaro OriginalPaper Pages: 188 - 195
A new role for diet in reducing the incidence of cardiovascular disease: Evidence from recent studies Penny M. Kris-Etherton Clinical Trials Review Pages: 185 - 187
The rationale for renewed interest by physicians in nutrition Thomas A. PearsonRoman BlochKecia Brown Invited Commentary Pages: 173 - 175
Oxidant stress in the vasculature Melanie MaytinJane LeopoldJoseph Loscalzo OriginalPaper Pages: 156 - 164
Lipid mediators that modulate the extracellular matrix structure and function in vascular cells Germán CamejoEva Hurt-CamejoGöran Bondjers OriginalPaper Pages: 142 - 149
Vascular biology, atherosclerosis, and implications for cardiac care Gerald S. BerensonS. R. SrinivasanB. Radhakrishnamurthy OriginalPaper Pages: 136 - 141
Gene therapy for atherosclerosis and atherosclerosis-related diseases Timo PakkanenSeppo Ylä-Herttuala OriginalPaper Pages: 123 - 130
The low-density lipoprotein receptor family: Genetics, function, and evolution Wolfgang Johann SchneiderJohannes NimpfMathias Drexler OriginalPaper Pages: 115 - 122
Susceptibility mutations for ischemic heart disease Børge G. NordestgaardAnne Tybjærg-Hansen Glostrup OriginalPaper Pages: 108 - 114
Dissection of the complex role of apolipoprotein E in lipoprotein metabolism and atherosclerosis using mouse models Ko Willems van DijkMarten H. HofkerLouis M. Havekes OriginalPaper Pages: 101 - 107
Biochemical evidence for a link between elevated levels of homocysteine and lipid peroxidation in vivo Jay W. Heinecke Invited Commentary Pages: 87 - 89
Genetics of familial combined hyperlipidemia Päivi PajukantaKimmo V. K. Porkka OriginalPaper Pages: 79 - 86
Common mutations of the lipoprotein lipase gene and their clinical significance Siegmund Gehrisch OriginalPaper Pages: 70 - 78
Gene therapy for dyslipidemia: Clinical prospects Daniel J. RaderUwe J. F. Tietge OriginalPaper Pages: 58 - 69
Small, dense low-density lipoprotein subclass pattern B: Issues for the clinician H. Robert Superko OriginalPaper Pages: 50 - 57
Combination drug therapy for dyslipidemia Khaldoon AlaswadJames H. O’Keefe JrRichard M. Moe OriginalPaper Pages: 44 - 49
The air force/texas coronary atherosclerosis prevention study: implications for preventive cardiology in the general adult US population Edwin Whitney OriginalPaper Pages: 38 - 43
Recent developments in the treatment of hypertriglyceridemia Patrick DuriezJean-Charles Fruchart OriginalPaper Pages: 31 - 37
New developments in the treatment of low high-density lipoprotein cholesterol Michael Miller OriginalPaper Pages: 24 - 30
Treatment of dyslipidemia: Genetic interactions with diet and drug therapy Jose M. OrdovasErnst J. Schaefer OriginalPaper Pages: 16 - 23
Prevention of cardiovascular events in elderly hypercholesterolemic patients Eric Bruckert OriginalPaper Pages: 9 - 15
Reducing atherothrombotic events in high-risk patients: Recent data on therapy with statins and fatty acids Christie M. Ballantyne Clinical Trials Review Pages: 6 - 8
Therapeutic impact of statin therapy in patients with low HDL cholesterol Antonio M. Gotto Jr. OriginalPaper Pages: 1 - 2
